Targeting Glomerular Injury with Sparsentan to Preserve Kidney Function in Patients with IgA
26:29
Treatment Options for FSGS and Minimal Change Disease
51:23
A Novel Approach to the Treatment of IgA Nephropathy
33:08
Treatment Options for Lupus Nephritis
32:33
I CAN Study, a phase 3 study for IgAN
1:11:47
Highlights from the KDIGO Guideline for ADPKD - ERKNet/ERA Webinar with Olivier Devuyst
49:17
Atacicept; A Novel Inhibitor of BAFF and APRIL In Development for the Treatment of IgAN
33:35
Beyond RAS Blockade: Dual Endothelin and Angiotensin Receptor Antagonism
59:08